Charlotte's Web Unveils New Scientific Advisory Board to Enhance Research Efforts

Charlotte's Web Moves Forward with Scientific Advisory Board

Charlotte's Web Holdings, Inc., a leader in the hemp-derived CBD wellness industry, has made an important announcement regarding the establishment of a Scientific Advisory Board. This strategic move aims to enhance the Company's medical channel approach and to accelerate its research and development (R&D) initiatives, further cementing its legacy as a science-backed innovator.

The Scientific Advisory Board is set to begin its operations in September 2025 and will focus on guiding the Company's R&D agenda. The goal is to shape clinical initiatives and translate botanical science into meaningful, patient-centric solutions. This initiative is not just an internal effort; it represents Charlotte's Web's commitment to patient access to verified, plant-based therapeutics, which have become increasingly significant in recent years.

A Legacy of Innovation

Founded over a decade ago, Charlotte's Web has been at the forefront of the hemp health movement, particularly following the story of Charlotte Figi, whose journey inspired a global surge in the acceptance of hemp-derived products. The Company has been renowned for its research-driven approach, focusing on safety and standardization in the rapidly evolving wellness market.

"Charlotte’s Web was built on the foundations of science, compassion, and innovation," remarked Bill Morachnick, CEO of Charlotte's Web. The company has maintained a strong partnership with Realm of Caring, a nonprofit organization focused on clinical research. The formation of the Scientific Advisory Board is viewed as a critical component in deepening Charlotte's Web's commitment to providing healthcare professionals with plant-based therapeutic options.

Addressing Healthcare Needs

As the demand for clinically relevant CBD solutions rises, the Scientific Advisory Board will provide insights into product formulations and educational initiatives for healthcare practitioners. This is vital for addressing the needs of patients suffering from issues such as pain, anxiety, and sleep disorders. Charlotte's Web also plans to develop Continuing Medical Education (CME) content to inform healthcare professionals, thereby creating a bridge between clinical practice and patient care.

In collaboration with DeFloria, Inc. and Ajna BioSciences PBC, Charlotte's Web is working on the botanical drug AJA001, which is a full-spectrum cannabidiol hemp extract aimed at treating irritability linked to autism spectrum disorder. This candidate has received FDA approval to advance into Phase 2 clinical trials, highlighting the potential of this partnership to deliver impactful solutions to challenging health conditions.

Expert Leadership

The new advisory board will be led by Dr. Marcel Bonn-Miller, a highly-regarded cannabis researcher with over two decades of experience and numerous published studies. According to Dr. Bonn-Miller, the establishment of this board marks a vital step forward in advancing the clinical relevance of hemp-based therapeutics. He emphasizes the goal is to convert rigorous research into practical solutions that cater to the needs of healthcare practitioners and patients alike.

Pioneering the Future

As Charlotte's Web continues to evolve, the company aims to set new national standards for plant-based health and wellness. The integrative approach of combining scientific expertise with practical applications is not only positioning the company as a leader but also making strides towards a future where plant-based medicine becomes more accessible and evidence-based.

With the formation of the Scientific Advisory Board, Charlotte's Web is poised to take bold steps that could reshape the landscape of cannabinoid science, bringing together university research, clinical practice, and patient care to enhance public health outcomes. As they embark on this new chapter, Charlotte's Web is dedicated to pioneering innovations that foster a healthier, more informed society.

About Charlotte's Web Holdings, Inc.

Charlotte's Web Holdings, Inc. is a Certified B Corporation based in Louisville, Colorado, and recognized as a botanical wellness innovation leader. The company offers a range of full-spectrum CBD extracts alongside broad-spectrum products and cannabinoid isolates. With a focus on quality and consistency, Charlotte's Web manages its entire production process, from cultivation to testing, ensuring products are safe and effective. Their offerings include a variety of CBD oils, gummies, topicals, and even products for pets. With a vertically integrated model, the company ensures rigorous standards for all their products, which are available via retailers and through their online store.